Kelly Rooks, Clive R Seed, Jesse J Fryk, Catherine A Hyland, Robert J Harley, Jerry A Holmberg, Denese C Marks, Robert L P Flower, Helen M Faddy
Dengue viruses (DENV 1-4) are a risk to transfusion safety, with several transfusion-transmitted (TT) cases reported globally. DENV 1-4 are endemic in over 100 countries, with seasonal outbreaks occurring in northeastern Australia. To mitigate TT-DENV risk in Australia, fresh blood components are not manufactured from donors returning from any area (domestic/overseas) with known dengue transmission. Alternatively, TT-DENV risk may be mitigated using an appropriate blood donor screening assay. We aimed to determine the rate of dengue infection in donors during dengue outbreaks in Australia...
2016: Journal of Blood Transfusion